We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Kidney fibrosis is the common end stage of various CKD including DKD.
2
However, not enough is known about the impact of a long-term cKD.
3
The mineral imbalance often seen in patients with CKD should be corrected.
4
Definitive studies are needed to determine long-term effects of DASH in CKD.
5
Background and objectives: Women affected by CKD increasingly choose to get pregnant.
1
Mutant analysis showed that crdA cells were delayed in development (12-24 h) and delayed in MbhA production relative to the wild type.
2
Methods: In SD rats CRD was used as noxious visceral stimuli.
3
Osteoporosis is a common complication in children with chronic rheumatic diseases (CRD).
4
Conclusion: The inputs of noxious CRD and acupuncture may interact at the spinal level.
5
The study protocol is published in the PROSPERO register CRD42016039137.
1
Patients: 1628 patients with chronickidneydisease participating in the MDRD Study.
2
Summary: Transplant recipients are a unique group of chronickidneydisease patients.
3
The trial enrolled 121 patients with moderate to severe chronickidneydisease.
4
These factors increase inflammation, oxidative stress, and progression of chronickidneydisease.
5
For example, how well is chronickidneydisease being managed at the moment?
1
Introduction: Terminal chronicrenalfailure is a truly global public health problem.
2
Renal morbidity included kidney transplantation, chronicrenalfailure, hypertensive renal disease, etc.
3
Results: Affected dogs developed proteinuria and rapidly progressive juvenile-onset chronicrenalfailure.
4
These observations may have prognostic and therapeutic implications in chronicrenalfailure.
5
She had also been suffering from anemia and mild chronicrenalfailure.
Usage of chronic renal insufficiency in English
1
Anemia is commonly observed among subjects with chronicrenalinsufficiency.
2
Background: Cardiovascular disorders are the leading cause of death in patients with chronicrenalinsufficiency.
3
These findings require confirmation by a large randomized trial conducted specifically in people with chronicrenalinsufficiency.
4
Several recently published reports have advanced our understanding of the epidemiology of anemia associated with chronicrenalinsufficiency.
5
Background: A potentially modifiable risk factor for cardiovascular disease in patients with mild chronicrenalinsufficiency is dyslipidemia.
6
This raises the concern that such diets might exacerbate the lipid problems already prevalent in chronicrenalinsufficiency.
7
Two control groups were formed by healthy volunteers (C) and non-diabetic subjects with chronicrenalinsufficiency (RI).
8
Cardiovascular disease is the main cause of death for patients with chronicrenalinsufficiency, particularly in patients with ESRD.
9
Objective: To determine whether pravastatin is effective and safe for secondary prevention of cardiovascular events in persons with chronicrenalinsufficiency.
10
The Reference Sheets list the most common nutrition-related concerns for chronicrenalinsufficiency, hemodialysis, peritoneal dialysis, and post kidney transplant patients.
11
We suggest that until better evidence becomes available, patients with chronicrenalinsufficiency should generally let their thirst guide fluid intake.
12
Conclusion: Sustained high urine volume and low Uosm are independent risk factors for faster GFR decline in patients with chronicrenalinsufficiency.
13
This study was conducted to determine whether pravastatin reduced rates of loss of renal function in people with moderate chronicrenalinsufficiency.
14
Limited data suggest that HMG-CoA reductase inhibitors (statins) may slow loss of renal function in individuals with chronicrenalinsufficiency.
15
Among those with chronicrenalinsufficiency or end-stage renal disease, detection of dyslipidemia requires more careful analysis and knowledge of normal pediatric ranges.
16
Since statins may be underused in this setting, physicians should consider prescribing them for patients with chronicrenalinsufficiency and known coronary disease.